Cardiology

New 'gene silencer' drug reduce cholesterol by over 50 percent

The findings come from the largest trial yet to test the safety and effectiveness of this kind of therapy. The technique, known as RNA interference (RNAi) therapy, essentially 'switches off' one of the genes responsible for ...

Cardiology

Statins may reduce the risk of blood clots in the vein

A study published by Dr Setor Kunutsor of the Musculoskeletal Research Unit in the School of Clinical Sciences, with colleagues from the University of Leicester, has confirmed that statins could play an important role in ...

Cardiology

New discovery at heart of healthy cereals

A new discovery at the University of Queensland could help reduce heart disease and boost nutrition security – the access to balanced nourishment - globally.

Cardiology

AHA: Inclisiran twice yearly may effectively control cholesterol

(HealthDay)—A new injectable medication called inclisiran cuts low-density lipoprotein (LDL) cholesterol by half or more, and the effect could last for four to six months, according to research presented at the annual meeting ...

Cardiology

PCSK9 inhibitors reduce lipoprotein (a) production

A new study published today in JACC: Basic to Translational Science sheds light on PCSK9 inhibitors, a new class of low density lipoprotein (LDL) lowering drugs, and their impact on another risk factor for heart disease, ...

page 18 from 38